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Abstract 
 
Because the right of EU citizens to be treated abroad was recognized by the Court of Justice of the European Union in several 
specific cases, starting with decisions dating back more than a decade, these decisions becoming part of the European acquis, 
this Article reviews the way in which the judgments of the Court of Justice of the European Union were refined within Directive 
2011/24/EU. In the field of cross-border medical services, a certain overlap is somehow reached between the law of the Union 
and the national law, so that European law in many cases is essentially limited to indicating a binding objective, i. e. the 
achievement of the free movement of citizens patients and their equal treatment, regardless of nationality, in relation to national 
authorities, while preserving the competence of the member states. Against this overlap and given that the European 
Commission has established the role of health as part of the 2020 strategy, the article aims to analyse how Romania obliged to 
submit to the regulatory framework imposed by primary and secondary legislation, manages to ensure the sustainability of the 
current model of the healthcare system, in order to increase its efficiency and effectiveness.  
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1. Introduction  
 
Article 35 of the Charter of Fundamental Rights of the European Union [1] provides that: „Everyone has the right of 
access to preventive health care and the right to benefit from medical treatment under the conditions established by 
national laws and practices. A high level of human health protection shall be ensured in the definition and implementation 
of all Union policies and activities. ” 
In exercising the powers which have been conferred in the interpretation of EU law, the Court of Justice of the 
European Union has developed over time a rich case law which has been refined with each application for a preliminary 
judgment submitted to the Court by the courts of the Member States. Thanks to the very rich case law in this area, the 
right of EU citizens to use free of constraints cross-border healthcare, which is generally known by the term “patient 
mobility", could be clearly outlined.  
The Court has paved the way for the implementation of the right recognized at Article 35 of the Charter of 
Fundamental Rights of the European Union for every person to have access to preventive healthcare and to benefit from 
medical treatment. Through the case law of the Court, restrictions could be eliminated in the form of national regulations, 
which stood in the way of creating an internal market in healthcare delivery.  
In our opinion, from the constant case law of the Court has have arisen certain important principles for the 
conditions in which, in accordance with the provisions on the freedom to provide services, patients are entitled to 
receiving medical care in other Member States and to the reimbursement of these treatment by the health insurance 
system to which they belong.  
The principles developed in that case law were considered components of the acquis of the EU, which the 
European legislator has taken into account in the development of Directive 2011/24/EU of the European Parliament and 
of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare [2].  
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2. Theory 
 
As part of the wider framework of services of general interest to the Union, health systems are a central component of 
social protection, and contribute both to social cohesion and social justice and to the sustainable development of the 
European Union.  
As stated in the Council Conclusions on Common values and principles in European Union Health Systems, 
“health is a value in itself" [3], also being a prerequisite for the economic prosperity of the Union. Human health affects 
economic performance in terms of productivity, employment, human capital and public spending.  
In this regard, the 2013 report on growth and cohesion [4] recognizes the role of healthcare in promoting social 
inclusion and combating poverty. To achieve the strategic objectives of the Union, providing access to high quality health 
care and the more efficient use of public resources, the document recommends reforming the health systems in order to 
ensure their profitability and sustainability, and its performance assessment.  
The Strategy for Sustainable Development [5] of the European Union cannot be achieved without investment in 
health, ensuring in this way, a smart, sustainable and inclusive growth of national health systems.  
Investing in health helps the Union to overcome the challenges identified in the EU Health Strategy [6], which were 
worsened by the economic crisis: an aging population, increasing chronic disease, a greater demand for health and the 
high cost of technological progress.  
Establishing the role of health as part of the 2020 strategy, the Commission has shown that the relatively large 
share of healthcare expenses in the total public expenditure, combined with the need for fiscal consolidation across the 
EU, requires more efficiency and effectiveness to ensure the sustainability of current models of health system [7].  
In order to remove the restrictions on the freedoms of European citizens, the cross-border healthcare directive 
creates a standard of protection at EU level within the harmonization of national policies in the field and targets the 
provision of healthcare services, thus ensuring patient mobility and the freedom of provision of health services. The 
directive regulates the provision of health services, irrespective of the organization, financing and delivery of these 
services.  
 
3. Results and Discussions 
 
As healthcare was excluded from the Directive 2006/123/EC [8] on services in the internal market, it has become 
imperative, in the European legal context, that these aspects be addressed through a legal instrument through which the 
principles established by the Court of Justice, on a case by case basis, be applied generally and effectively.  
The right of EU citizens to get treated abroad was recognized by the Court of Justice of the European Union in 
several specific cases, starting with decisions dating back more than a decade, these decisions becoming part of the 
European acquis. However, individual decisions of the Court have not been assimilated coherently by national 
legislations, practically existing many situations in which patients were forced to solve problems of access to treatment 
abroad on their own by taking the entire legal route to the Court of Justice. Unfortunately, often the Court's decision came 
only after the patient's death, although a saving treatment would have been possible in a Member State other than that of 
residence.  
Given the fact that at European level, planned and emergency treatment costs abroad represent only about 1% of 
public expenditure for healthcare [9], the simplification of the access procedure to cross-border medical services has 
become a moral imperative.  
The problem of the legislative gap between Member States has become more visible with the adoption of the 
Treaty of Lisbon [10].  Treaty requires common standards at the level of social and medical assistance (Articles 34 and 
35) and explicitly encourages, in particular, „ cooperation between the Member States to improve the complementarity of 
their health services in cross-border areas. ” (article 152). Complementary to the rights of citizens under the Treaty, has 
emerged the need for a European law that clarifies the responsibilities of Member States towards the patients.  
The road towards the harmonization of medical services in Europe, opened by the introduction of the European 
Health Insurance Card, ought to continue with a pan-European development of patients' rights. From the earliest days of 
European integration and to date, the European institutions have actively promoted intra-European movement. The 
initiative to introduce a European Health Insurance Card to replace the prior necessary documents to access medical 
treatment during a temporary stay in another country falls within the same general phenomenon.  
Since around the values expressed by the case law of the Court of Justice of the European Union there have been 
a number of uncertainties, which made them difficult to apply in practice, this development of patients’ rights did not occur 
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ab initio, requiring the intervention of the European legislator to clarify the situation through a directive to support the 
provision of cross-border healthcare, both for the benefit of patients and of the national health service.  
• In the field of cross-border medical services, a certain overlap is somehow reached between the law of the 
Union and the national law, so that European law in many cases is essentially limited to indicating a binding 
objective, i. e. the achievement of the free movement of citizens patients and their equal treatment, regardless 
of nationality, in relation to national authorities, while preserving the competence of the member states.  
Against this overlap member states are obliged to submit to the regulatory framework imposed by primary and 
secondary legislation, to the extent that they are not allowed to violate EU law when exercising their powers.  
Important institution of the European Union, the Court of Justice is the one that assesses the scope of the EU legal 
framework established by Article 49 EC for the exercise of the competences of the Member States. It is also incumbent 
on the Court, assigned by the founding treaties, that by the interpretation given to a provision of European law, to clarify 
and specify its meaning and scope, such as to be understood and applied from the time of its entry into force.  
The main principles proclaimed by Directive 2011/24/EU law have their legal source in a long series of cases in 
which the Court identified the limits imposed by the EU legislation on the restrictions in Member States of the right of 
patients to use medical services across national borders within the European internal market.  
Thus, patients citizens are free to choose the Member State of the European Union and the preferred institution for 
medical treatment, social insurance offices in the State of residence assuming treatment costs in the same proportion as 
in at national level.  
The European regulatory framework, aiming a new scheme of monitoring the services provided, was created 
precisely to enhance the quality and safety of healthcare services. The free movement of patients, without the legal force 
of European regulation, would have produced a competition between the health systems of the Member States in order to 
attract more patients. There is the risk that the free access to cross-border medical services may produce a drop in the 
price of medical services throughout the European Union to the detriment of the quality of health services.  
The new cross-border healthcare system favours rare disease patients, whose treatment requires costly 
investments in research. The existence on the European internal market of health services of specialized hospitals on 
these diseases prevents the waste of resources due to the parallel investment in equipment and research and also 
provides for closer cooperation between Member States in terms of health.  
The Directive clarifies the rights of citizens to access safe and good quality treatment across the EU and its 
reimbursement. Europeans prefer to receive healthcare close to home: no one wants to travel further than they should 
when they are ill. However, sometimes people have to go abroad, because experience or the medical care they need is 
not available within the national borders. Or simply because the nearest hospital is across the border.  
However, from the application of the provisions of the Directive are exempted certain health care services such as, 
for example, long-term services, whose purpose is to support people who need help with daily routine tasks.  
For OECD, long-term care is "a political issue of confluence, which brings together a range of services for people 
who are dependent on help in basic activities of daily living over an extended period of time". National definitions on long-
term care vary within the European Union, and reflect the differences in the length of stay, range of beneficiaries and the 
often unclear boundary between health (health care) services and non-medical (social) services. Some countries prefer, 
for example, to focus on early rehabilitation outpatient treatment, while others focus more on providing care in hospitals or 
similar institutions. Long-term care can include rehabilitation, basic medical treatment, home health care, social care, 
housing and services such as transportation, food, occupational assistance and help in managing daily activities [11].  
In the field of cross-border medical services, a certain overlap is somehow reached between the law of the Union 
and the national law, so that European law in many cases is essentially limited to indicating a binding objective, i. e. the 
achievement of the free movement of citizens patients and their equal treatment, regardless of nationality, in relation to 
national authorities, while preserving the competence of the member states. Directive 2011/24/EU preserves the 
competences of the Member States, which are obliged to submit to the regulatory framework imposed by primary law and 
secondary legislation, to the extent that Member States must not violate EU law when exercising their powers.  
As argued in the Watts judgment, Member States are obliged to adapt their national healthcare and social security 
systems [12]. Moreover, the Court emphasized since its previous decisions that Member States must comply with EU 
law, in particular with the provisions on the freedom to provide services [13].  
Those provisions prohibit Member States from introducing or maintaining unjustified restrictions on the freedom to 
provide of medical care services [14].  
In addition, the Court case law expressly emphasized that the mandatory adaptations of national social security 
systems aiming to achieve the fundamental freedoms guaranteed by the Treaty should not be considered by Member 
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States as interference in their sovereign competence in the field of public health [15].  
We believe that should not remain unmentioned the fact that the European Union can exert considerable influence 
on the health systems of Member States, for example, by measures designed to achieve fundamental freedoms [16].  
The Directive is without prejudice to the laws, regulations and administrative provisions of the Member States 
relating to the organization and financing of healthcare in situations not related to cross-border healthcare. In particular, 
nothing in this Directive obliges a Member State to reimburse the costs of healthcare provided by healthcare providers 
established on its territory if those providers are not part of the social security system or national health system of that 
State Member State.  
From the interpretation of the text, in conjunction with Article 3, paragraph 1 letters (a) - (c) of Directive 
2005/36/EC, follows that it does not matter whether the work performed by a qualified person (as is the sanitary field, 
such as the analysed case) has a temporary or occasional basis. As the promotion of the provision of services must be 
ensured in the context of the strict compliance with public health and safety and the protection of the consumer, Member 
States have special provisions in the national legislation for professions regulated at sector level with implications in 
terms of health.  
Given the different systems established on the one hand, for the provision of temporary and occasional cross-
border services and, on the other hand, for establishment, it is necessary to specify criteria for distinguishing between 
these two concepts in the case of the movement of the service provider on the territory of the host Member State.  
The fundamental right to privacy with regard to the processing of personal data is protected in conformity with 
Member States' national measures for implementing Union provisions on the protection of personal data, in particular 
Directives 95/46/EC [17] and 2002/58/EC [18].  
For a better understanding of this issue, we shall discuss the laws of Romania concerning the processing of 
personal data and on the free movement of such data, Law no. 677 of 2001 [19], to analyse how these rules apply to 
public health in general and, in particular, on cross-border healthcare.  
Thus, the processing of personal data related to racial or ethnic origin, political, religious, philosophical or similar 
nature opinions, the union membership, as well as personal data concerning health or sex life is prohibited. This provision 
shall not apply where the subject has given their express consent to such processing.  
Regarding the prior express consent we believe that, regarding healthcare, the mere presentation of the patient to 
a health service provider, amounts to a tacit consent, so we cannot discuss express consent. It is inevitable that the 
supplier request personal data, even for an appointment for diagnosis, (name, address, telephone number, affection 
suspected or confirmed by someone else etc. ).  
The National Law, Law no. 677/2001, provides for special rules on the processing of personal data concerning 
health. According to this regulation, healthcare professionals, medical care institutions and their staff may process 
personal data on health status, without the authorization of the supervisory authority, only if the processing is necessary 
to protect the life, physical integrity or health of the concerned person.  
To detail how personal data concerning health can be processed by service providers, the law provides that this 
operation can be performed only by a health professional or under its supervision, subject to professional secrecy.  
We believe that the competent national authorities in public health should regulate more differentiated all aspects 
of the patient's right to confidentiality, to reduce the risks of disclosing personal data on the health of citizens. In our 
opinion and in the absence of these legislative differentiations, information that normally would not be provided to the 
public appears in the mass media.  
 
4. Conclusions 
 
Within health systems throughout the European Union there are a number of common principles of operation [20], which 
have been affirmed by the case law of the Court of Justice of the European Union. These principles must be applied 
uniformly in national health systems, both to strengthen the confidence of patients in cross-border healthcare, a 
prerequisite for achieving patient mobility, and to ensure a high level of health protection.  
Referring to the decisions of national authorities on market mechanisms and the pressure of competition to 
manage health systems, the Council was of the view that decisions about the health care package which citizens are 
entitled to and the respective mechanisms used to finance and provide healthcare, must be placed in the national context 
of the Member States.  
Under the Treaty on the Functioning of the European Union [21], at the basis of all European policies lies the aim 
to ensure a high level of human health protection, a major goal of the whole Union. This goal is also considered when the 
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European legislator adopts acts under other Treaty provisions.  
Most of the provisions of Directive 2011/24/EU aim to improve the functioning of the internal market and free 
movement of goods, persons and services in healthcare. Given this, the legal basis for the adoption of Directive 
2011/24/EU is found in Article 114 TFEU. Union legislation is based on this legal basis even when public health 
protection is a decisive factor in the choices made, Article 114 TFEU explicitly stating that in this regard, a high level of 
human health protection must be ensured, taking account in particular of any new development based on scientific data.  
From the case law of the Court of Justice of the European Union unequivocally results that people normally 
resident in a Member State operating a national health service, are entitled to receiving hospital treatment in another 
Member State at the expense of the national health service.  
Member States may condition this right by the requirement that the person concerned should have obtained prior 
authorization, only if such authorization is based on objective, non-discriminatory and transparent criteria within a 
procedure system. In addition, applications for the authorization of treatment abroad must be analysed objectively and 
impartially, within a reasonable time, and the national health authority's refusal to grant such authorization can be 
challenged in court or out of court. The absence of such criteria and the lack of easily accessible and transparent 
procedures cannot deprive a person of this right. Also, if the conditions for authorization (form E112) are designed to 
safeguard the financial stability of the national health system, considerations of a purely budgetary or economic nature 
cannot justify a refusal to grant such authorization.  
To determine whether the treatment is available without undue delay might be considered the waiting time and the 
priority to treatment granted by the national health authority, only on condition that they are based on concrete indications 
relating to the patient's condition at the time of evaluation, as well as its medical history and the prognosis for the patient 
seeking treatment.  
Under European law, the affiliate Member State is obliged to fund the hospital treatment carried out in another 
Member State and the reimbursement of this treatment is based on national legislation. In the absence of tariffs or rates 
for calculating the amount of reimbursement, the reimbursement must be calculated at the actual cost of the treatment. 
Travel and accommodation costs related to hospital treatment received in another Member State are reimbursable only 
where this is provided for by national law for treatment on national territory.  
Regarding the obligation of a Member State to reimburse the cost of hospital treatment provided in another 
Member State of the European Union, Article 49 EC does not allow to take into account budgetary reasons, unless it is 
demonstrated that compliance with this obligation on a more general scale would threaten the financial balance of the 
respective national health system. Moreover, in accordance with Article 22 (2) of Regulation EEC No.  1408/71 [22], 
budgetary considerations cannot be taken into account in decisions refusing prior authorization for treatment abroad.  
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